IMC-RON8

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IMC-RON8, covering 2019-02-15 to 2019-02-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study of IMC-RON8 in Advanced Solid Tumors [Phase 1]